🇺🇸 FDA
Patent

US 7563446

Methods and compositions for inducing autoimmunity in the treatment of cancers

granted A61KA61K2039/6081A61K2039/627

Quick answer

US patent 7563446 (Methods and compositions for inducing autoimmunity in the treatment of cancers) held by The Board of Regents of the University of Texas System expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jul 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2039/6081, A61K2039/627, A61K31/685, A61K39/385